A detailed history of Crossmark Global Holdings, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 246,414 shares of MRK stock, worth $24.2 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
246,414
Previous 189,308 30.17%
Holding current value
$24.2 Million
Previous $23.4 Million 19.4%
% of portfolio
0.5%
Previous 0.45%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$111.15 - $128.97 $6.35 Million - $7.36 Million
57,106 Added 30.17%
246,414 $28 Million
Q2 2024

Jul 29, 2024

BUY
$123.8 - $132.96 $756,418 - $812,385
6,110 Added 3.34%
189,308 $23.4 Million
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $941,703 - $1.1 Million
-8,316 Reduced 4.34%
183,198 $24.2 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $692,744 - $753,873
6,915 Added 3.75%
191,514 $20.9 Million
Q3 2023

Nov 08, 2023

SELL
$102.95 - $114.33 $2.39 Million - $2.66 Million
-23,249 Reduced 11.19%
184,599 $19.1 Million
Q2 2023

Jul 31, 2023

BUY
$108.61 - $118.38 $1.63 Million - $1.77 Million
14,978 Added 7.77%
207,848 $22.1 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $1.53 Million - $1.71 Million
14,909 Added 8.38%
192,870 $20.5 Million
Q4 2022

Jan 19, 2023

SELL
$87.44 - $112.11 $3.08 Million - $3.94 Million
-35,169 Reduced 16.5%
177,961 $19.7 Million
Q3 2022

Nov 01, 2022

BUY
$84.53 - $94.96 $1.52 Million - $1.7 Million
17,927 Added 9.18%
213,130 $18.4 Million
Q2 2022

Jul 29, 2022

BUY
$83.49 - $94.64 $2 Million - $2.27 Million
24,002 Added 14.02%
195,203 $17.8 Million
Q1 2022

May 11, 2022

SELL
$73.51 - $82.4 $851,760 - $954,768
-11,587 Reduced 6.34%
171,201 $14 Million
Q4 2021

Jan 10, 2022

BUY
$72.28 - $90.54 $181,278 - $227,074
2,508 Added 1.39%
182,788 $14 Million
Q3 2021

Oct 21, 2021

BUY
$71.68 - $78.83 $12 Million - $13.2 Million
167,508 Added 1311.53%
180,280 $13.5 Million
Q3 2021

Oct 13, 2021

SELL
$71.68 - $78.83 $12.1 Million - $13.3 Million
-168,586 Reduced 92.96%
12,772 $576,000
Q2 2021

Jul 21, 2021

BUY
$70.31 - $77.77 $8.89 Million - $9.83 Million
126,374 Added 229.84%
181,358 $14.1 Million
Q1 2021

Apr 15, 2021

BUY
$68.86 - $81.11 $279,158 - $328,819
4,054 Added 7.96%
54,984 $4.24 Million
Q4 2020

Jan 14, 2021

SELL
$71.77 - $79.65 $95,167 - $105,615
-1,326 Reduced 2.54%
50,930 $4.17 Million
Q3 2020

Oct 08, 2020

SELL
$73.18 - $82.95 $94,621 - $107,254
-1,293 Reduced 2.41%
52,256 $4.34 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $87,109 - $99,120
1,237 Added 2.36%
53,549 $4.14 Million
Q1 2020

Apr 28, 2020

SELL
$63.36 - $87.82 $66,654 - $92,386
-1,052 Reduced 1.97%
52,312 $3.84 Million
Q4 2019

Feb 06, 2020

BUY
$77.58 - $87.54 $43,755 - $49,372
564 Added 1.07%
53,364 $4.85 Million
Q3 2019

Oct 09, 2019

SELL
$76.08 - $82.93 $874,083 - $952,782
-11,489 Reduced 17.87%
52,800 $4.45 Million
Q2 2019

Jul 09, 2019

BUY
$69.84 - $81.59 $48,049 - $56,133
688 Added 1.08%
64,289 $5.39 Million
Q1 2019

May 02, 2019

SELL
$69.58 - $79.36 $137,350 - $156,656
-1,974 Reduced 3.01%
63,601 $5.29 Million
Q4 2018

Jan 31, 2019

BUY
$65.24 - $75.71 $122,585 - $142,259
1,879 Added 2.95%
65,575 $5.01 Million
Q3 2018

Nov 08, 2018

BUY
$57.69 - $67.84 $284,988 - $335,129
4,940 Added 8.41%
63,696 $4.52 Million
Q2 2018

Jul 31, 2018

SELL
$50.83 - $59.72 $608,943 - $715,445
-11,980 Reduced 16.94%
58,756 $3.57 Million
Q1 2018

Apr 16, 2018

SELL
$50.96 - $59.23 $128,062 - $148,844
-2,513 Reduced 3.43%
70,736 $3.85 Million
Q4 2017

Feb 05, 2018

SELL
$51.62 - $61.64 $27,823 - $33,223
-539 Reduced 0.73%
73,249 $4.12 Million
Q3 2016

Oct 25, 2017

BUY
N/A
73,788
73,788 $4.73 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.